PPA
CUE icon

Parametric Portfolio Associates’s Cue Biopharma CUE Stock Holding History

Parametric Portfolio Associates’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$163K Sell
1,116
-148
-12% -$31.4K ﹤0.01% 3487
2021
Q4 		$429K Sell
1,264
-11
-0.9% -$4.25K ﹤0.01% 3125
2021
Q3 		$557K Buy
1,275
+370
+41% +$129K ﹤0.01% 3057
2021
Q2 		$316K Buy
905
+236
+35% +$91.5K ﹤0.01% 3253
2021
Q1 		$245K Buy
669
+135
+25% +$55.6K ﹤0.01% 3797
2020
Q4 		$200K Buy
534
+24
+5% +$9.59K ﹤0.01% 3777
2020
Q3 		$230K Sell
510
-57
-10% -$32.8K ﹤0.01% 3598
2020
Q2 		$417K Buy
567
+182
+47% +$132K ﹤0.01% 3348
2020
Q1 		$164K Buy
+385
New +$187K ﹤0.01% 3604
2019
Q4 		– Sell
-336
Closed -$85K – 3968
2019
Q3 		$85K Buy
+336
New +$80.7K ﹤0.01% 3853

Other funds holding CUE

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return